Chloroquine modulates inflammatory autoimmune responses through Nurr1 in autoimmune diseases
For over a half-century the anti-malarial drug chloroquine (CQ) has been used as a therapeutic agent, alone or in combination, to treat autoimmune diseases. However, neither the underlying mechanism(s) of action nor their molecular target(s) are well defined. The orphan nuclear receptor Nurr1 (also...
| Autors principals: | , , , , , , , , |
|---|---|
| Altres autors: | |
| Format: | Journal Article |
| Idioma: | English |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://hdl.handle.net/10356/142409 |